TP53 and ATM co-mutation predicts response to immune checkpoint inhibitors in non-small cell lung cancer

Y. Chen, G. Chen, J. Li, Chen Huang, Yuexin Li, Jianhua Lin, Lisheng Chen, Jianping Lu, Y.q. Wang, Chaolian Wang, Lucy Pan, X.f. Xia, Xin Yi, C.b. Chen, Xiaojuan Zheng, Zengqing Guo, Jianji PanAnnals 2019 · DOI

BibTeX
@article{chen2019tp,
  author = {Y. Chen and G. Chen and J. Li and Chen Huang and Yuexin Li and Jianhua Lin and Lisheng Chen and Jianping Lu and Y.Q. Wang and Chaolian Wang and Lucy Pan and X.F. Xia and Xin Yi and C.B. Chen and Xiaojuan Zheng and Zengqing Guo and Jianji Pan},
  title = {{TP53 and ATM co-mutation predicts response to immune checkpoint inhibitors in non-small cell lung cancer}},
  journal = {Annals},
  year = {2019},
  doi = {10.1093/annonc/mdz253.066},
}

Loading related content...

Figure